Terns Pharmaceuticals (TERN) Cash from Operations (2020 - 2025)
Terns Pharmaceuticals filings provide 6 years of Cash from Operations readings, the most recent being 19083000.0 for Q4 2025.
- Quarterly Cash from Operations fell 30.85% to 19083000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 82176000.0 through Dec 2025, down 17.37% year-over-year, with the annual reading at 82176000.0 for FY2025, 17.37% down from the prior year.
- Cash from Operations hit 19083000.0 in Q4 2025 for Terns Pharmaceuticals, up from 19773000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8082000.0 in Q3 2021 and bottomed at 24440000.0 in Q1 2025.
- Average Cash from Operations over 5 years is 15525900.0, with a median of 14483000.0 recorded in 2023.
- The largest annual shift saw Cash from Operations crashed 96.46% in 2021 before it rose 24.5% in 2024.
- Terns Pharmaceuticals' Cash from Operations stood at 10669000.0 in 2021, then dropped by 5.08% to 11211000.0 in 2022, then tumbled by 72.3% to 19316000.0 in 2023, then grew by 24.5% to 14584000.0 in 2024, then crashed by 30.85% to 19083000.0 in 2025.
- Per Business Quant, the three most recent readings for TERN's Cash from Operations are 19083000.0 (Q4 2025), 19773000.0 (Q3 2025), and 18880000.0 (Q2 2025).